Shopping Cart
- Remove All
- Your shopping cart is currently empty
ZINC00784494 is a selective inhibitor of LCN2 (lipocalin-2), which inhibits cancer cell proliferation and reduces AKT phosphorylation levels, prevents the transition of the cell cycle from the G0/G1 phase to the S phase, and promotes apoptosis. It can be used for the study of inflammatory breast cancer (IBC).
Description | ZINC00784494 is a selective inhibitor of LCN2 (lipocalin-2), which inhibits cancer cell proliferation and reduces AKT phosphorylation levels, prevents the transition of the cell cycle from the G0/G1 phase to the S phase, and promotes apoptosis. It can be used for the study of inflammatory breast cancer (IBC). |
In vitro | Method: Cell viability assay was performed to evaluate the effect of ZINC00784494 on SUM149 cells. Cells were exposed to various concentrations of ZINC00784494 (0.01 to 100 µM) and incubated for 72 hours. Result: ZINC00784494 significantly reduced the viability of SUM149 cells at concentrations of 1 µM or lower. [1] |
Alias | ZINC 00784494 |
Molecular Weight | 362.4 |
Formula | C20H14N2O3S |
Cas No. | 317328-17-9 |
Smiles | O=C1OC=2C=CC=CC2C=C1C=3N=C(SC3)NC4=CC=CC(=C4)C(=O)C |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (220.75 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.